Recce Pharmaceuticals has a highly experienced management team made up of individuals who have significant experience in all aspects of international technology; biopharmaceutical development and commercialisation. The team is responsible for the strategic direction, operations and success of the business.
US based, current Chairman and Co-founder of Palatin Technologies, Inc. (NYSE: PTN) and Lead Director of Heat Biologics, Inc. (NASDAQ: HTBX) – extensive experience in the international commercialisation of pharmaceutical technologies.
Founder and inventor. Former Executive Director and Head of Research at Johnson & Johnson (Aus) in Sydney, with global responsibilities, particularly in Asia-Pacific.
Co-inventor and qualified medical scientist; specialisation in medical microbiology and regulatory affairs.
Extensive experience in marketing, business development and commercialisation of early stage technologies with global potential.
A quality control expert who has worked with leading pharmaceutical companies according to international regulatory standards.
Highly qualified in chemical engineering and microbiology, has significant experience taking a new technology concept to pilot plant and full-scale to FDA standards and production internationally.
Alistair is a qualified lawyer and Principal/Managing Director of McKeough & Whittens. Alistair has broad experience as a commercial litigator and Company Secretary to ASX Listed companies.
Justin is a qualified accountant and Partner of Pitcher Partners Sydney. Justin has broad experience covering all areas of accounting, taxation and assurance. Particularly, Justin’s areas of expertise are business services and outsourced accounting.
Receive news and information direct to your inbox.
ASX: